BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND CEACAM5, CEA AND Treatment
18 results:

  • 1. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
    Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
    Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [testicular malignant Leydig cell tumor: A case report].
    Lu W; Zhang M; Wang SP; Wang X; Cai ZM
    Zhonghua Nan Ke Xue; 2016 May; 22(5):442-5. PubMed ID: 27416670
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence of testicular carcinoma, therapy and quality assesment.
    Junuzovic D; Mehmedbasic S; Mehmedbasic E; Spahovic A
    Med Arh; 2011; 65(3):164-7. PubMed ID: 21776879
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Adenocarcinoma of the rete testis. A case report].
    Hagiuda J; Matsumoto M; Hanawa Y; Ishikawa H; Marumo K
    Nihon Hinyokika Gakkai Zasshi; 2010 Nov; 101(7):749-53. PubMed ID: 21174741
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [testicular mesothelioma. Report of a case].
    Loizaga A; Eguileor J; Arceo R; Ullate V; Unda M; Larrínaga JR; Flores N
    Actas Urol Esp; 1995; 19(7):573-6. PubMed ID: 8815671
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Teratoma of testis--a case report].
    Tan LB; Chen BR; Huang WH; Tarn JJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jun; 9(6):377-80. PubMed ID: 8340962
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum AFP, hCG and cea in the management of patients with testicular, ovarian and extragonadal germ cell tumors.
    Motawy MS; Szymendera JJ; al-Jazzaf H; Behbehani AE; Foudeh MO; Ebraheem AK; Nasralla MY; Ali MA
    Int J Biol Markers; 1992; 7(2):80-6. PubMed ID: 1378875
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Carcinoembryonic antigen levels in germ cell tumours.
    Hitchins RN; Rustin GJ; Mitchell HD; Newlands ES; Begent RH; Bagshawe KD
    Int J Biol Markers; 1989; 4(1):31-4. PubMed ID: 2545794
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
    Jacobsen GK; Olsen J
    Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors.
    Szymendera JJ; Kozłowicz-Gudzinska I; Madej G; Sikorowa L; Kaminska JA; Kowalska M
    Oncology; 1985; 42(4):253-8. PubMed ID: 2409496
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of five tumor markers (AFP, cea, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Biological markers in lung cancer: an immunocytochemical approach.
    Heyderman E; Chapman DV; Richardson TC
    Cancer Detect Prev; 1982; 5(4):427-49. PubMed ID: 6189609
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis.
    Jacobsen GK; Jacobsen M; Clausen PP
    Am J Surg Pathol; 1981 Apr; 5(3):257-66. PubMed ID: 7195154
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.